nodes	percent_of_prediction	percent_of_DWPC	metapath
Atenolol—Infarction—Sorafenib—liver cancer	0.062	0.0621	CcSEcCtD
Atenolol—Cardiogenic shock—Epirubicin—liver cancer	0.0304	0.0304	CcSEcCtD
Atenolol—Cardiogenic shock—Doxorubicin—liver cancer	0.0281	0.0281	CcSEcCtD
Atenolol—Alopecia reversible—Epirubicin—liver cancer	0.028	0.0281	CcSEcCtD
Atenolol—Respiratory distress—Sorafenib—liver cancer	0.0271	0.0271	CcSEcCtD
Atenolol—Alopecia reversible—Doxorubicin—liver cancer	0.0259	0.026	CcSEcCtD
Atenolol—Oropharyngeal discomfort—Sorafenib—liver cancer	0.0237	0.0237	CcSEcCtD
Atenolol—Cardiomegaly—Epirubicin—liver cancer	0.0174	0.0175	CcSEcCtD
Atenolol—Cardiomegaly—Doxorubicin—liver cancer	0.0161	0.0162	CcSEcCtD
Atenolol—Cardiac failure congestive—Sorafenib—liver cancer	0.0138	0.0138	CcSEcCtD
Atenolol—Dermatitis exfoliative—Sorafenib—liver cancer	0.0132	0.0133	CcSEcCtD
Atenolol—Cardiac failure—Sorafenib—liver cancer	0.0128	0.0128	CcSEcCtD
Atenolol—Pain in extremity—Sorafenib—liver cancer	0.0125	0.0125	CcSEcCtD
Atenolol—Mood swings—Sorafenib—liver cancer	0.0118	0.0119	CcSEcCtD
Atenolol—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.0113	0.0113	CcSEcCtD
Atenolol—Abdominal discomfort—Sorafenib—liver cancer	0.0104	0.0104	CcSEcCtD
Atenolol—Psoriasis—Epirubicin—liver cancer	0.0101	0.0101	CcSEcCtD
Atenolol—Erectile dysfunction—Sorafenib—liver cancer	0.00995	0.00996	CcSEcCtD
Atenolol—Renal failure—Sorafenib—liver cancer	0.00947	0.00948	CcSEcCtD
Atenolol—Myocardial infarction—Sorafenib—liver cancer	0.00944	0.00945	CcSEcCtD
Atenolol—Psoriasis—Doxorubicin—liver cancer	0.00937	0.00938	CcSEcCtD
Atenolol—Epistaxis—Sorafenib—liver cancer	0.00909	0.00909	CcSEcCtD
Atenolol—Rash erythematous—Epirubicin—liver cancer	0.00831	0.00832	CcSEcCtD
Atenolol—Tinnitus—Sorafenib—liver cancer	0.00806	0.00807	CcSEcCtD
Atenolol—Flushing—Sorafenib—liver cancer	0.00803	0.00803	CcSEcCtD
Atenolol—Arrhythmia—Sorafenib—liver cancer	0.00773	0.00773	CcSEcCtD
Atenolol—Rash erythematous—Doxorubicin—liver cancer	0.00769	0.0077	CcSEcCtD
Atenolol—Alopecia—Sorafenib—liver cancer	0.00764	0.00765	CcSEcCtD
Atenolol—Syncope—Sorafenib—liver cancer	0.00675	0.00676	CcSEcCtD
Atenolol—Loss of consciousness—Sorafenib—liver cancer	0.00662	0.00662	CcSEcCtD
Atenolol—Cough—Sorafenib—liver cancer	0.00657	0.00658	CcSEcCtD
Atenolol—Atrioventricular block—Epirubicin—liver cancer	0.00656	0.00657	CcSEcCtD
Atenolol—Ventricular tachycardia—Epirubicin—liver cancer	0.00637	0.00637	CcSEcCtD
Atenolol—Abnormal dreams—Epirubicin—liver cancer	0.00629	0.0063	CcSEcCtD
Atenolol—Dry mouth—Sorafenib—liver cancer	0.00627	0.00627	CcSEcCtD
Atenolol—Atrioventricular block—Doxorubicin—liver cancer	0.00607	0.00608	CcSEcCtD
Atenolol—Shock—Sorafenib—liver cancer	0.00605	0.00605	CcSEcCtD
Atenolol—Thrombocytopenia—Sorafenib—liver cancer	0.00602	0.00602	CcSEcCtD
Atenolol—Ventricular tachycardia—Doxorubicin—liver cancer	0.00589	0.00589	CcSEcCtD
Atenolol—Dry eye—Epirubicin—liver cancer	0.00588	0.00588	CcSEcCtD
Atenolol—Anorexia—Sorafenib—liver cancer	0.00586	0.00586	CcSEcCtD
Atenolol—Abnormal dreams—Doxorubicin—liver cancer	0.00582	0.00583	CcSEcCtD
Atenolol—Pulmonary oedema—Epirubicin—liver cancer	0.00567	0.00567	CcSEcCtD
Atenolol—Dyspnoea—Sorafenib—liver cancer	0.00548	0.00548	CcSEcCtD
Atenolol—Dry eye—Doxorubicin—liver cancer	0.00544	0.00544	CcSEcCtD
Atenolol—Dyspepsia—Sorafenib—liver cancer	0.00541	0.00541	CcSEcCtD
Atenolol—Decreased appetite—Sorafenib—liver cancer	0.00534	0.00535	CcSEcCtD
Atenolol—Gastrointestinal disorder—Sorafenib—liver cancer	0.0053	0.00531	CcSEcCtD
Atenolol—Fatigue—Sorafenib—liver cancer	0.0053	0.0053	CcSEcCtD
Atenolol—Pain—Sorafenib—liver cancer	0.00525	0.00526	CcSEcCtD
Atenolol—Constipation—Sorafenib—liver cancer	0.00525	0.00526	CcSEcCtD
Atenolol—Pulmonary oedema—Doxorubicin—liver cancer	0.00524	0.00525	CcSEcCtD
Atenolol—Vascular purpura—Epirubicin—liver cancer	0.00516	0.00517	CcSEcCtD
Atenolol—Cardiac failure congestive—Epirubicin—liver cancer	0.00509	0.0051	CcSEcCtD
Atenolol—Hot flush—Epirubicin—liver cancer	0.00494	0.00494	CcSEcCtD
Atenolol—Dermatitis exfoliative—Epirubicin—liver cancer	0.0049	0.0049	CcSEcCtD
Atenolol—Menopausal symptoms—Epirubicin—liver cancer	0.0049	0.0049	CcSEcCtD
Atenolol—Body temperature increased—Sorafenib—liver cancer	0.00486	0.00486	CcSEcCtD
Atenolol—Purpura—Epirubicin—liver cancer	0.00479	0.0048	CcSEcCtD
Atenolol—Vascular purpura—Doxorubicin—liver cancer	0.00478	0.00478	CcSEcCtD
Atenolol—Cardiac failure—Epirubicin—liver cancer	0.00473	0.00474	CcSEcCtD
Atenolol—Lethargy—Epirubicin—liver cancer	0.00471	0.00472	CcSEcCtD
Atenolol—Cardiac failure congestive—Doxorubicin—liver cancer	0.00471	0.00472	CcSEcCtD
Atenolol—Pain in extremity—Epirubicin—liver cancer	0.00462	0.00462	CcSEcCtD
Atenolol—Hot flush—Doxorubicin—liver cancer	0.00457	0.00457	CcSEcCtD
Atenolol—Affect lability—Epirubicin—liver cancer	0.00455	0.00455	CcSEcCtD
Atenolol—Dermatitis exfoliative—Doxorubicin—liver cancer	0.00453	0.00453	CcSEcCtD
Atenolol—Menopausal symptoms—Doxorubicin—liver cancer	0.00453	0.00453	CcSEcCtD
Atenolol—Purpura—Doxorubicin—liver cancer	0.00444	0.00444	CcSEcCtD
Atenolol—Asthenia—Sorafenib—liver cancer	0.00441	0.00441	CcSEcCtD
Atenolol—Cardiac arrest—Epirubicin—liver cancer	0.00439	0.0044	CcSEcCtD
Atenolol—Cardiac failure—Doxorubicin—liver cancer	0.00438	0.00438	CcSEcCtD
Atenolol—Mood swings—Epirubicin—liver cancer	0.00438	0.00438	CcSEcCtD
Atenolol—Lethargy—Doxorubicin—liver cancer	0.00436	0.00437	CcSEcCtD
Atenolol—Pruritus—Sorafenib—liver cancer	0.00435	0.00435	CcSEcCtD
Atenolol—Ataxia—Epirubicin—liver cancer	0.00434	0.00435	CcSEcCtD
Atenolol—Pain in extremity—Doxorubicin—liver cancer	0.00428	0.00428	CcSEcCtD
Atenolol—Orthostatic hypotension—Epirubicin—liver cancer	0.00422	0.00422	CcSEcCtD
Atenolol—Affect lability—Doxorubicin—liver cancer	0.00421	0.00421	CcSEcCtD
Atenolol—Diarrhoea—Sorafenib—liver cancer	0.0042	0.00421	CcSEcCtD
Atenolol—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00416	0.00416	CcSEcCtD
Atenolol—Cardiac arrest—Doxorubicin—liver cancer	0.00407	0.00407	CcSEcCtD
Atenolol—Dizziness—Sorafenib—liver cancer	0.00406	0.00407	CcSEcCtD
Atenolol—Mood swings—Doxorubicin—liver cancer	0.00405	0.00405	CcSEcCtD
Atenolol—Ataxia—Doxorubicin—liver cancer	0.00402	0.00402	CcSEcCtD
Atenolol—Orthostatic hypotension—Doxorubicin—liver cancer	0.0039	0.00391	CcSEcCtD
Atenolol—Rash—Sorafenib—liver cancer	0.00387	0.00388	CcSEcCtD
Atenolol—Dermatitis—Sorafenib—liver cancer	0.00387	0.00387	CcSEcCtD
Atenolol—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00385	0.00385	CcSEcCtD
Atenolol—Headache—Sorafenib—liver cancer	0.00385	0.00385	CcSEcCtD
Atenolol—Nausea—Sorafenib—liver cancer	0.00365	0.00365	CcSEcCtD
Atenolol—Drowsiness—Epirubicin—liver cancer	0.00356	0.00356	CcSEcCtD
Atenolol—Renal failure—Epirubicin—liver cancer	0.0035	0.0035	CcSEcCtD
Atenolol—Sweating—Epirubicin—liver cancer	0.00341	0.00342	CcSEcCtD
Atenolol—Epistaxis—Epirubicin—liver cancer	0.00336	0.00336	CcSEcCtD
Atenolol—Agranulocytosis—Epirubicin—liver cancer	0.00332	0.00333	CcSEcCtD
Atenolol—Drowsiness—Doxorubicin—liver cancer	0.00329	0.0033	CcSEcCtD
Atenolol—Bradycardia—Epirubicin—liver cancer	0.00325	0.00326	CcSEcCtD
Atenolol—Renal failure—Doxorubicin—liver cancer	0.00324	0.00324	CcSEcCtD
Atenolol—Sweating—Doxorubicin—liver cancer	0.00316	0.00316	CcSEcCtD
Atenolol—Epistaxis—Doxorubicin—liver cancer	0.00311	0.00311	CcSEcCtD
Atenolol—Visual impairment—Epirubicin—liver cancer	0.00308	0.00308	CcSEcCtD
Atenolol—Agranulocytosis—Doxorubicin—liver cancer	0.00307	0.00308	CcSEcCtD
Atenolol—Bradycardia—Doxorubicin—liver cancer	0.00301	0.00301	CcSEcCtD
Atenolol—Tinnitus—Epirubicin—liver cancer	0.00298	0.00298	CcSEcCtD
Atenolol—Flushing—Epirubicin—liver cancer	0.00297	0.00297	CcSEcCtD
Atenolol—Arrhythmia—Epirubicin—liver cancer	0.00286	0.00286	CcSEcCtD
Atenolol—Visual impairment—Doxorubicin—liver cancer	0.00285	0.00285	CcSEcCtD
Atenolol—Alopecia—Epirubicin—liver cancer	0.00282	0.00283	CcSEcCtD
Atenolol—Tinnitus—Doxorubicin—liver cancer	0.00276	0.00276	CcSEcCtD
Atenolol—Flushing—Doxorubicin—liver cancer	0.00274	0.00275	CcSEcCtD
Atenolol—Tension—Epirubicin—liver cancer	0.00273	0.00273	CcSEcCtD
Atenolol—Nervousness—Epirubicin—liver cancer	0.0027	0.0027	CcSEcCtD
Atenolol—Arrhythmia—Doxorubicin—liver cancer	0.00264	0.00264	CcSEcCtD
Atenolol—Vision blurred—Epirubicin—liver cancer	0.00262	0.00262	CcSEcCtD
Atenolol—Alopecia—Doxorubicin—liver cancer	0.00261	0.00262	CcSEcCtD
Atenolol—Ill-defined disorder—Epirubicin—liver cancer	0.00258	0.00258	CcSEcCtD
Atenolol—Tension—Doxorubicin—liver cancer	0.00253	0.00253	CcSEcCtD
Atenolol—Malaise—Epirubicin—liver cancer	0.00251	0.00251	CcSEcCtD
Atenolol—Nervousness—Doxorubicin—liver cancer	0.0025	0.0025	CcSEcCtD
Atenolol—Vertigo—Epirubicin—liver cancer	0.0025	0.0025	CcSEcCtD
Atenolol—Syncope—Epirubicin—liver cancer	0.0025	0.0025	CcSEcCtD
Atenolol—Palpitations—Epirubicin—liver cancer	0.00246	0.00246	CcSEcCtD
Atenolol—Loss of consciousness—Epirubicin—liver cancer	0.00245	0.00245	CcSEcCtD
Atenolol—Cough—Epirubicin—liver cancer	0.00243	0.00243	CcSEcCtD
Atenolol—Vision blurred—Doxorubicin—liver cancer	0.00243	0.00243	CcSEcCtD
Atenolol—Ill-defined disorder—Doxorubicin—liver cancer	0.00239	0.00239	CcSEcCtD
Atenolol—Chest pain—Epirubicin—liver cancer	0.00237	0.00237	CcSEcCtD
Atenolol—Anxiety—Epirubicin—liver cancer	0.00236	0.00236	CcSEcCtD
Atenolol—Discomfort—Epirubicin—liver cancer	0.00234	0.00234	CcSEcCtD
Atenolol—Malaise—Doxorubicin—liver cancer	0.00232	0.00232	CcSEcCtD
Atenolol—Dry mouth—Epirubicin—liver cancer	0.00232	0.00232	CcSEcCtD
Atenolol—Vertigo—Doxorubicin—liver cancer	0.00231	0.00231	CcSEcCtD
Atenolol—Syncope—Doxorubicin—liver cancer	0.00231	0.00231	CcSEcCtD
Atenolol—Confusional state—Epirubicin—liver cancer	0.00229	0.00229	CcSEcCtD
Atenolol—Palpitations—Doxorubicin—liver cancer	0.00228	0.00228	CcSEcCtD
Atenolol—Oedema—Epirubicin—liver cancer	0.00227	0.00227	CcSEcCtD
Atenolol—Loss of consciousness—Doxorubicin—liver cancer	0.00226	0.00226	CcSEcCtD
Atenolol—Cough—Doxorubicin—liver cancer	0.00225	0.00225	CcSEcCtD
Atenolol—Shock—Epirubicin—liver cancer	0.00223	0.00224	CcSEcCtD
Atenolol—Thrombocytopenia—Epirubicin—liver cancer	0.00222	0.00223	CcSEcCtD
Atenolol—Tachycardia—Epirubicin—liver cancer	0.00222	0.00222	CcSEcCtD
Atenolol—Hyperhidrosis—Epirubicin—liver cancer	0.0022	0.0022	CcSEcCtD
Atenolol—Chest pain—Doxorubicin—liver cancer	0.00219	0.00219	CcSEcCtD
Atenolol—Anxiety—Doxorubicin—liver cancer	0.00218	0.00219	CcSEcCtD
Atenolol—Discomfort—Doxorubicin—liver cancer	0.00217	0.00217	CcSEcCtD
Atenolol—Anorexia—Epirubicin—liver cancer	0.00216	0.00217	CcSEcCtD
Atenolol—Dry mouth—Doxorubicin—liver cancer	0.00214	0.00215	CcSEcCtD
Atenolol—Hypotension—Epirubicin—liver cancer	0.00212	0.00212	CcSEcCtD
Atenolol—Confusional state—Doxorubicin—liver cancer	0.00212	0.00212	CcSEcCtD
Atenolol—Oedema—Doxorubicin—liver cancer	0.0021	0.0021	CcSEcCtD
Atenolol—Shock—Doxorubicin—liver cancer	0.00207	0.00207	CcSEcCtD
Atenolol—Thrombocytopenia—Doxorubicin—liver cancer	0.00206	0.00206	CcSEcCtD
Atenolol—Insomnia—Epirubicin—liver cancer	0.00205	0.00206	CcSEcCtD
Atenolol—Tachycardia—Doxorubicin—liver cancer	0.00205	0.00205	CcSEcCtD
Atenolol—Paraesthesia—Epirubicin—liver cancer	0.00204	0.00204	CcSEcCtD
Atenolol—Hyperhidrosis—Doxorubicin—liver cancer	0.00203	0.00203	CcSEcCtD
Atenolol—Dyspnoea—Epirubicin—liver cancer	0.00202	0.00203	CcSEcCtD
Atenolol—Somnolence—Epirubicin—liver cancer	0.00202	0.00202	CcSEcCtD
Atenolol—Anorexia—Doxorubicin—liver cancer	0.002	0.002	CcSEcCtD
Atenolol—Dyspepsia—Epirubicin—liver cancer	0.002	0.002	CcSEcCtD
Atenolol—Decreased appetite—Epirubicin—liver cancer	0.00197	0.00198	CcSEcCtD
Atenolol—Hypotension—Doxorubicin—liver cancer	0.00196	0.00197	CcSEcCtD
Atenolol—Gastrointestinal disorder—Epirubicin—liver cancer	0.00196	0.00196	CcSEcCtD
Atenolol—Fatigue—Epirubicin—liver cancer	0.00196	0.00196	CcSEcCtD
Atenolol—Pain—Epirubicin—liver cancer	0.00194	0.00194	CcSEcCtD
Atenolol—Constipation—Epirubicin—liver cancer	0.00194	0.00194	CcSEcCtD
Atenolol—Insomnia—Doxorubicin—liver cancer	0.0019	0.0019	CcSEcCtD
Atenolol—Paraesthesia—Doxorubicin—liver cancer	0.00189	0.00189	CcSEcCtD
Atenolol—Dyspnoea—Doxorubicin—liver cancer	0.00187	0.00187	CcSEcCtD
Atenolol—Feeling abnormal—Epirubicin—liver cancer	0.00187	0.00187	CcSEcCtD
Atenolol—Somnolence—Doxorubicin—liver cancer	0.00187	0.00187	CcSEcCtD
Atenolol—Dyspepsia—Doxorubicin—liver cancer	0.00185	0.00185	CcSEcCtD
Atenolol—Decreased appetite—Doxorubicin—liver cancer	0.00183	0.00183	CcSEcCtD
Atenolol—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00181	0.00182	CcSEcCtD
Atenolol—Fatigue—Doxorubicin—liver cancer	0.00181	0.00181	CcSEcCtD
Atenolol—Pain—Doxorubicin—liver cancer	0.0018	0.0018	CcSEcCtD
Atenolol—Constipation—Doxorubicin—liver cancer	0.0018	0.0018	CcSEcCtD
Atenolol—Body temperature increased—Epirubicin—liver cancer	0.0018	0.0018	CcSEcCtD
Atenolol—Feeling abnormal—Doxorubicin—liver cancer	0.00173	0.00173	CcSEcCtD
Atenolol—Body temperature increased—Doxorubicin—liver cancer	0.00166	0.00166	CcSEcCtD
Atenolol—Asthenia—Epirubicin—liver cancer	0.00163	0.00163	CcSEcCtD
Atenolol—Pruritus—Epirubicin—liver cancer	0.00161	0.00161	CcSEcCtD
Atenolol—Diarrhoea—Epirubicin—liver cancer	0.00155	0.00156	CcSEcCtD
Atenolol—Asthenia—Doxorubicin—liver cancer	0.00151	0.00151	CcSEcCtD
Atenolol—Dizziness—Epirubicin—liver cancer	0.0015	0.0015	CcSEcCtD
Atenolol—Pruritus—Doxorubicin—liver cancer	0.00149	0.00149	CcSEcCtD
Atenolol—Diarrhoea—Doxorubicin—liver cancer	0.00144	0.00144	CcSEcCtD
Atenolol—Rash—Epirubicin—liver cancer	0.00143	0.00143	CcSEcCtD
Atenolol—Dermatitis—Epirubicin—liver cancer	0.00143	0.00143	CcSEcCtD
Atenolol—Headache—Epirubicin—liver cancer	0.00142	0.00142	CcSEcCtD
Atenolol—Dizziness—Doxorubicin—liver cancer	0.00139	0.00139	CcSEcCtD
Atenolol—Nausea—Epirubicin—liver cancer	0.00135	0.00135	CcSEcCtD
Atenolol—Rash—Doxorubicin—liver cancer	0.00132	0.00133	CcSEcCtD
Atenolol—Dermatitis—Doxorubicin—liver cancer	0.00132	0.00132	CcSEcCtD
Atenolol—Headache—Doxorubicin—liver cancer	0.00132	0.00132	CcSEcCtD
Atenolol—Nausea—Doxorubicin—liver cancer	0.00125	0.00125	CcSEcCtD
Atenolol—Ibuprofen—PPARG—liver cancer	0.000421	0.507	CrCbGaD
Atenolol—Propranolol—CYP1A1—liver cancer	0.00025	0.302	CrCbGaD
Atenolol—Ibuprofen—ALB—liver cancer	0.000158	0.191	CrCbGaD
